Sanofi SA (LTS:0A2V)
$ 49 0 (0%) Market Cap: 122.85 Bil Enterprise Value: 141.18 Bil PE Ratio: 28.19 PB Ratio: 1.63 GF Score: 87/100

Sanofi SA R&D Day Transcript

Jun 23, 2020 / 01:00PM GMT
Release Date Price: $52.82 (+3.04%)
John C. Reed
Sanofi - Executive VP and Global Head of Research & Development

We're putting a lot of emphasis on the pace of delivery. We want to deliver it with more urgency, a pace that patients will be proud of. On a journey to improve R&D productivity, we brought in a whole new research team. We're establishing new capabilities for drug discovery. It's a journey, but we feel like we're making progress, and we need to stay committed to that progress.

Yong Jun Liu
Sanofi - Head of Research, Global R&D

Hello, everybody. I'm Yong-Jun Liu, the Global Head of Research at Sanofi. My expertise is in immunology. My 30 years research experience has generated 3 innovative medicines in the clinic, in the field of oncology, immunology and allergy.

Dietmar P. Berger
Sanofi - Chief Medical Officer & Global Head of Development

My name is Dietmar Berger. I'm the Head of Global Development and the Chief Medical Officer for Sanofi. I'm a hematologist oncologist by training, and I'm excited to work on a broader

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot